Open AccessEarly Alteration of Kidney Function in Nonuremic Type 1 Diabetic Islet Transplant Recipients Under Tacrolimus-Mycophenolate Therapy
Author(s) -
Pieter Gillard,
Maria Rustandi,
Achmad Efendi,
Da Hae Lee,
Zhidong Ling,
Robert Hilbrands,
Dirk Kuypers,
Chantal Mathieu,
Daniel Jacobs-Tulleneers-Thevissen,
Frans Gorus,
Daniël Pipeleers,
Bart Keymeulen
Publication year - 2014
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000000086
Subject(s) - tacrolimus , medicine , urology , albuminuria , kidney transplantation , calcineurin , transplantation , discontinuation , population , immunosuppression , renal function , mycophenolic acid , belatacept , kidney transplant , environmental health
Transplant patients on tacrolimus therapy exhibit a reduced glomerular filtration rate (GFR). The type of graft and immune treatment protocol may influence the extent and reversibility of this side effect.